| Scientific Program | ||
| Stream 1 | Stream 2 | Stream 3 |
Stream 3: Breaking Cancer Therapy
| Session 3-1: Lung Cancer | |
|
Day 1: Afternoon, Friday, October 11, 2019 Place: Room 618, 6th Floor, Dalian International Conference Center |
|
| Chair: Dr. Yinling Hu, Professor, National Cancer Institute, National Institutes of Health, USA | |
|
Time
|
Speeches and Speakers |
|
15:30-15:35
|
Chair's Introduction |
|
15:35-16:00
|
Title: Lung Cancer-cell Signaling Drives Immunosuppressive Responses in the Tumor Microenvironment Dr. Yinling Hu, Professor, National Cancer Institute, National Institutes of Health, USA |
|
16:00-16:25
|
Title: Repurposing of Curcumin and Paclitaxel as Inhaled Formulation to Treat Lung Cancer Dr. Wing-Hin Lee, Senior Lecturer, Universiti Kuala Lumpur, Malaysia |
|
16:25-16:50
|
Title: Strategies for Development of Inhalable Formulation To Treat Lung Cancer: Effects of Particle Size Dr. Judy Loo Ching Yee, Senior Lecturer, Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur (RCMP UniKL), Malaysia |
|
16:50-17:15
|
Speech Opportunity Available Abstract and Biography: Submit Here |
| Session 3-2: Breast Cancer, Cervical and Ovarian Cancer |
|
|
Day 2: Morning, Sunday, October 13, 2019 Place: Room 618, 6th Floor, Dalian International Conference Center |
|
| Chair: Dr. Pranela Rameshwar, Professor of Medicine, Division of Hematology and Oncology, Rutgers New Jersey Medical School, USA | |
|
Time
|
Speeches and Speakers |
|
08:30-08:35
|
Chair's Introduction |
|
08:35-09:00
|
Title: Nucleolin Identifies Breast Tumours Associated with Poor Prognosis Dr. Philippe Bouvet, Professor, Cancer Research Center of Lyon, France |
|
09:00-09:25
|
Title: Dedifferentiation of Breast Cancer Cells at the Bone Marrow/Peripheral Interface |
| 09:25-09:50 |
Title: Control of PD-L1 Expression by miR-140/142/340/383 in Cervical Cancer |
|
09:50-10:15
|
Speech Opportunity Available Abstract and Biography: Submit Here |
|
10:15-10:30
|
Coffee Break |
| Session 3-3: Blood Cancer | |
|
Day 3: Morning, Sunday, October 13, 2019 Place: Room 618, 6th Floor, Dalian International Conference Center |
|
| Chair: Dr. Jinming Song, Associate Professor, Moffitt Cancer Center and University of South Florida Morsani Medical School, USA | |
|
Time
|
Speeches and Speakers |
|
10:30-10:35
|
Chair's Introduction |
|
10:35-10:55
|
Title: Infectious Complications Associated with Chimeric Antigen Receptor T-Cell (CART) Therapy Dr. Patrick B. Johnston, Assistant Professor of Medicine, Mayo Clinic, USA |
|
10:55-11:15
|
Title: The Novel Bispecific CD47-CD19 Antibody TG-1801 Potentiates the Activity of Ublituximab-Umbralisib (U2) Drug Combination in Preclinical Models of B-cell Non-Hodgkin Lymphoma Dr. Gaël Roué, Senior Scientist, Vall d'Hebron Institute of Oncology (VHIO), Spain |
|
11:15-11:35
|
Title: Hairy Cell Leukemia and Its Atypical Presentations Dr. Jinming Song, Associate Professor, Moffitt Cancer Center and University of South Florida Morsani Medical School, USA |
| 11:35-11:55 | Title: 10x Genomics Solutions for Multi-omics Single-cell Analysis of Cancer Dr. Joseph Aman, FAS Manager APAC, 10x Genomics, Inc, USA |
|
11:55-12:15
|
Speech Opportunity Available Abstract and Biography: Submit Here |
| ©2016-2020 All right reserved by BIT Congress Inc. Tel: 0086-411-84799609, Fax: 0086-411-84796897 |
